ACHV
Achieve Life Sciences, Inc.
Price Chart
Latest Quote
$4.30
Current Price| Previous Close | $4.18 |
| Open | $4.18 |
| Day High | $4.35 |
| Day Low | $4.06 |
| Volume | 430,390 |
Stock Information
| Shares Outstanding | 53.23M |
| Total Debt | $9.96M |
| Cash Equivalents | $48.11M |
| Net Income | $-52.35M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $228.91M |
| EPS (TTM) | $-1.35 |
| Exchange | NCM |
📊 Custom Metrics & Score
Score: 13/42| Debt to Equity | 0.48 |
| Debt to Earnings | -0.25 |
| Current Ratio | 5.46 |
| Quick Ratio | 5.14 |
| Return on Equity | -190.57% |
| Avg FCF Growth | 0.28% |
| FCF Yield | -13.01% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $4.30 | 450,119 |
| 2026-01-30 | $4.18 | 769,300 |
| 2026-01-29 | $4.34 | 899,400 |
| 2026-01-28 | $4.36 | 863,100 |
| 2026-01-27 | $4.61 | 2,586,600 |
| 2026-01-26 | $5.09 | 1,108,600 |
| 2026-01-23 | $5.60 | 468,100 |
| 2026-01-22 | $5.52 | 543,400 |
| 2026-01-21 | $5.42 | 864,900 |
| 2026-01-20 | $5.49 | 972,400 |
| 2026-01-16 | $5.83 | 1,262,200 |
| 2026-01-15 | $5.59 | 297,700 |
| 2026-01-14 | $5.61 | 360,000 |
| 2026-01-13 | $5.52 | 454,100 |
| 2026-01-12 | $5.66 | 685,700 |
| 2026-01-09 | $5.56 | 873,900 |
| 2026-01-08 | $5.47 | 1,085,200 |
| 2026-01-07 | $5.20 | 702,500 |
| 2026-01-06 | $4.99 | 732,200 |
| 2026-01-05 | $5.19 | 722,600 |
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
📰 Latest News
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
Insider Monkey • 2026-02-03T00:32:25Z
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future
Simply Wall St. • 2026-01-17T12:57:30Z
Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the most
Simply Wall St. • 2025-11-29T12:11:00Z
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation
Insider Monkey • 2025-11-25T13:40:09Z
Achieve Life Sciences Inc (ACHV) Q3 2025 Earnings Call Highlights: Strategic Advances and ...
GuruFocus.com • 2025-11-06T21:01:33Z
FDA Grants First CNPV Vouchers, Igniting Rally in Biotech Stocks
GuruFocus.com • 2025-10-20T12:25:07Z
Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed
Simply Wall St. • 2025-10-19T13:12:40Z
A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy
Simply Wall St. • 2025-10-18T09:08:59Z
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly.
Investor's Business Daily • 2025-10-17T20:21:54Z
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
Benzinga • 2025-08-21T18:11:26Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $2,180,000 | $2,853,000 | $1,789,000 | $0 |
| Total Expenses | $39,069,000 | $27,250,000 | $40,800,000 | $33,094,000 |
| Other Income Expense | $-934,000 | $-537,000 | $40,000 | $-75,000 |
| Other Non Operating Income Expenses | $-30,000 | $-9,000 | $40,000 | $-75,000 |
| Net Non Operating Interest Income Expense | $176,000 | $-2,028,000 | $-1,590,000 | $17,000 |
| Interest Expense Non Operating | $2,180,000 | $2,853,000 | $1,789,000 | $0 |
| Operating Expense | $39,069,000 | $27,250,000 | $40,800,000 | $33,094,000 |
| General And Administrative Expense | $16,252,000 | $11,436,000 | $10,722,000 | $9,128,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Net Interest Income | $176,000 | $-2,028,000 | $-1,590,000 | $17,000 |
| Interest Income | $2,356,000 | $825,000 | $199,000 | $17,000 |
| Normalized Income | $-38,923,000 | $-29,287,000 | $-42,350,000 | $-33,152,000 |
| Net Income From Continuing And Discontinued Operation | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Net Income Common Stockholders | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Net Income | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Net Income Including Noncontrolling Interests | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Net Income Continuous Operations | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Pretax Income | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Special Income Charges | $-904,000 | $-528,000 | $0 | $0 |
| Interest Income Non Operating | $2,356,000 | $825,000 | $199,000 | $17,000 |
| Operating Income | $-39,069,000 | $-27,250,000 | $-40,800,000 | $-33,094,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
| Basic EPS | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-36,514,000 | $-26,206,000 | $-40,325,000 | $-32,902,000 |
| Total Unusual Items | $-904,000 | $-528,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-904,000 | $-528,000 | $0 | $0 |
| Reconciled Depreciation | $229,000 | $228,000 | $236,000 | $250,000 |
| EBITDA (Bullshit earnings) | $-37,418,000 | $-26,734,000 | $-40,325,000 | $-32,902,000 |
| EBIT | $-37,647,000 | $-26,962,000 | $-40,561,000 | $-33,152,000 |
| Diluted Average Shares | $32,071,146 | $19,827,354 | $10,593,034 | $8,119,836 |
| Basic Average Shares | $32,071,146 | $19,827,354 | $10,593,034 | $8,119,836 |
| Diluted NI Availto Com Stockholders | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Other Special Charges | $283,000 | - | - | - |
| Restructuring And Mergern Acquisition | $621,000 | $528,000 | $0 | $0 |
| Research And Development | $22,817,000 | $15,814,000 | $30,078,000 | $23,966,000 |
| Selling General And Administration | $16,252,000 | $11,436,000 | $10,722,000 | $9,128,000 |
| Other Gand A | $16,252,000 | $11,436,000 | $10,722,000 | $9,128,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $18,891,000 | $-3,679,000 | $5,851,000 | $25,367,000 |
| Total Assets | $38,633,000 | $19,371,000 | $29,971,000 | $47,516,000 |
| Total Non Current Assets | $2,166,000 | $2,389,000 | $2,641,000 | $2,922,000 |
| Other Non Current Assets | $39,000 | $92,000 | $66,000 | $183,000 |
| Goodwill And Other Intangible Assets | $2,008,000 | $2,231,000 | $2,452,000 | $2,675,000 |
| Other Intangible Assets | $974,000 | $1,197,000 | $1,418,000 | $1,641,000 |
| Current Assets | $36,467,000 | $16,982,000 | $27,330,000 | $44,594,000 |
| Other Current Assets | $2,107,000 | $1,325,000 | $2,454,000 | $1,419,000 |
| Restricted Cash | $20,000 | $50,000 | $50,000 | - |
| Receivables | $0 | $111,000 | $105,000 | $153,000 |
| Cash Cash Equivalents And Short Term Investments | $34,340,000 | $15,496,000 | $24,721,000 | $43,022,000 |
| Cash And Cash Equivalents | $12,733,000 | $15,496,000 | $24,721,000 | $43,022,000 |
| Cash Equivalents | $12,135,000 | $14,252,000 | $22,756,000 | $41,859,000 |
| Cash Financial | $598,000 | $1,244,000 | $1,965,000 | $1,163,000 |
| Other Receivables | - | $111,000 | $105,000 | $153,000 |
| Prepaid Assets | - | - | - | $1,419,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $9,958,000 | $16,731,000 | $16,198,000 | $14,993,000 |
| Long Term Debt And Capital Lease Obligation | $9,903,000 | $6,000 | $69,000 | $14,924,000 |
| Long Term Debt | $9,837,000 | - | - | $14,920,000 |
| Current Debt And Capital Lease Obligation | $55,000 | $16,725,000 | $16,129,000 | $69,000 |
| Net Debt | - | $1,166,000 | - | - |
| Current Debt | - | $16,662,000 | $16,071,000 | - |
| Other Current Borrowings | - | $16,662,000 | $16,071,000 | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $17,734,000 | $20,819,000 | $21,668,000 | $19,474,000 |
| Total Non Current Liabilities Net Minority Interest | $11,052,000 | $6,000 | $69,000 | $14,924,000 |
| Other Non Current Liabilities | $1,149,000 | - | - | - |
| Current Liabilities | $6,682,000 | $20,813,000 | $21,599,000 | $4,550,000 |
| Payables And Accrued Expenses | $3,600,000 | $1,249,000 | $3,792,000 | $2,541,000 |
| Payables | $1,950,000 | $618,000 | $1,660,000 | $841,000 |
| Accounts Payable | $1,950,000 | $618,000 | $1,660,000 | $841,000 |
| Other Current Liabilities | - | $528,000 | - | - |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $20,899,000 | $-1,448,000 | $8,303,000 | $28,042,000 |
| Total Equity Gross Minority Interest | $20,899,000 | $-1,448,000 | $8,303,000 | $28,042,000 |
| Stockholders Equity | $20,899,000 | $-1,448,000 | $8,303,000 | $28,042,000 |
| Gains Losses Not Affecting Retained Earnings | $31,000 | $4,000 | $4,000 | $4,000 |
| Other Equity Adjustments | $31,000 | $4,000 | $4,000 | $4,000 |
| Retained Earnings | $-205,578,000 | $-165,751,000 | $-135,936,000 | $-93,586,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $34,685,072 | $21,165,760 | $17,897,029 | $9,453,542 |
| Share Issued | $34,685,072 | $21,165,760 | $17,897,029 | $9,453,542 |
| Tangible Book Value | $18,891,000 | $-3,679,000 | $5,851,000 | $25,367,000 |
| Invested Capital | $30,736,000 | $15,214,000 | $24,374,000 | $42,962,000 |
| Working Capital | $29,785,000 | $-3,831,000 | $5,731,000 | $40,044,000 |
| Capital Lease Obligations | $121,000 | $69,000 | $127,000 | $73,000 |
| Total Capitalization | $30,736,000 | $-1,448,000 | $8,303,000 | $42,962,000 |
| Additional Paid In Capital | $226,343,000 | $164,209,000 | $144,148,000 | $121,545,000 |
| Capital Stock | $103,000 | $90,000 | $87,000 | $79,000 |
| Common Stock | $103,000 | $90,000 | $87,000 | $79,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $66,000 | $6,000 | $69,000 | $4,000 |
| Current Capital Lease Obligation | $55,000 | $63,000 | $58,000 | $69,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,027,000 | $2,311,000 | $1,678,000 | $1,940,000 |
| Current Accrued Expenses | $1,650,000 | $631,000 | $2,132,000 | $1,700,000 |
| Goodwill | $1,034,000 | $1,034,000 | $1,034,000 | $1,034,000 |
| Net PPE | $119,000 | $66,000 | $123,000 | $64,000 |
| Gross PPE | $119,000 | $66,000 | $123,000 | $64,000 |
| Other Properties | $119,000 | $66,000 | $123,000 | $64,000 |
| Other Short Term Investments | $21,607,000 | $0 | - | - |
| Accumulated Depreciation | - | - | $-299,000 | $-287,000 |
| Leases | - | - | $25,000 | $26,000 |
| Machinery Furniture Equipment | - | - | $259,000 | $257,000 |
| Properties | - | - | $0 | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-29,770,000 | $-24,500,000 | $-37,569,000 | $-29,440,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-29,770,000 | $-24,479,000 | $-37,569,000 | $-29,440,000 |
| Cash Flow From Continuing Operating Activities | $-29,770,000 | $-24,479,000 | $-37,569,000 | $-29,440,000 |
| Operating Gains Losses | $283,000 | - | - | - |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Investing Cash Flow | $-21,580,000 | $-21,000 | $0 | $0 |
| Cash Flow From Continuing Investing Activities | $-21,580,000 | $-21,000 | $0 | $0 |
| Capital Expenditure | - | $-21,000 | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $0 | $-30,000 | - | - |
| Issuance Of Capital Stock | $56,076,000 | $15,301,000 | $19,212,000 | $21,343,000 |
| Financing Cash Flow | $48,527,000 | $15,278,000 | $19,315,000 | $36,610,000 |
| Cash Flow From Continuing Financing Activities | $48,527,000 | $15,278,000 | $19,315,000 | $36,610,000 |
| Net Other Financing Charges | $-114,000 | $-220,000 | $-47,000 | - |
| Net Common Stock Issuance | $56,076,000 | $15,271,000 | $19,212,000 | $21,343,000 |
| Common Stock Issuance | $56,076,000 | $15,301,000 | $19,212,000 | $21,343,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-18,109,000 | $0 | $0 | - |
| Issuance Of Debt | $9,814,000 | $0 | $0 | $14,929,000 |
| End Cash Position | $12,773,000 | $15,596,000 | $24,821,000 | $43,072,000 |
| Beginning Cash Position | $15,596,000 | $24,821,000 | $43,072,000 | $35,903,000 |
| Effect Of Exchange Rate Changes | $0 | $-3,000 | $3,000 | $-1,000 |
| Changes In Cash | $-2,823,000 | $-9,222,000 | $-18,254,000 | $7,170,000 |
| Proceeds From Stock Option Exercised | $860,000 | $227,000 | $150,000 | $338,000 |
| Common Stock Payments | $0 | $-30,000 | - | - |
| Net Issuance Payments Of Debt | $-8,295,000 | $0 | $0 | $14,929,000 |
| Net Long Term Debt Issuance | $-8,295,000 | $0 | $0 | $14,929,000 |
| Long Term Debt Payments | $-18,109,000 | $0 | $0 | - |
| Long Term Debt Issuance | $9,814,000 | $0 | $0 | $14,929,000 |
| Net Investment Purchase And Sale | $-21,580,000 | $0 | $0 | $0 |
| Sale Of Investment | $26,307,000 | $0 | $0 | $0 |
| Purchase Of Investment | $-47,887,000 | $0 | $0 | $0 |
| Net PPE Purchase And Sale | $0 | $-21,000 | $0 | $0 |
| Purchase Of PPE | $0 | $-21,000 | $0 | $0 |
| Change In Working Capital | $2,412,000 | $-778,000 | $79,000 | $1,234,000 |
| Change In Other Current Liabilities | $-1,000 | $-58,000 | $-5,000 | $-14,000 |
| Change In Payables And Accrued Expense | $3,067,000 | $-1,890,000 | $967,000 | $1,629,000 |
| Change In Accrued Expense | $1,735,000 | $-848,000 | $168,000 | $1,120,000 |
| Change In Payable | $1,332,000 | $-1,042,000 | $799,000 | $509,000 |
| Change In Account Payable | $1,332,000 | $-1,042,000 | $799,000 | $509,000 |
| Change In Prepaid Assets | $-765,000 | $1,176,000 | $-931,000 | $-228,000 |
| Change In Receivables | $111,000 | $-6,000 | $48,000 | $-153,000 |
| Other Non Cash Items | $1,808,000 | $2,447,000 | $1,196,000 | $41,000 |
| Stock Based Compensation | $5,325,000 | $3,439,000 | $3,270,000 | $2,187,000 |
| Depreciation Amortization Depletion | $229,000 | $228,000 | $236,000 | $250,000 |
| Depreciation And Amortization | $229,000 | $228,000 | $236,000 | $250,000 |
| Net Income From Continuing Operations | $-39,827,000 | $-29,815,000 | $-42,350,000 | $-33,152,000 |
| Change In Other Working Capital | - | - | $-263,000 | $466,000 |
| Amortization Cash Flow | - | - | - | $223,000 |
| Amortization Of Intangibles | - | - | - | $223,000 |
| Depreciation | - | - | - | $27,000 |